医学
癌症
融合
肿瘤科
内科学
数学
哲学
语言学
作者
Alison M. Schram,Kōichi Goto,Dong-Wan Kim,Teresa Macarulla,Antoine Hollebecque,Eileen M. O’Reilly,Sai‐Hong Ignatius Ou,Jordi Rodón,Sun Young Rha,Kazumi Nishino,M. Duruisseaux,Joon Oh Park,Cindy Neuzillet,Stephen V. Liu,Benjamin A. Weinberg,James M. Cleary,Emiliano Calvo,Kumiko Umemoto,Misako Nagasaka,Christoph Springfeld
标识
DOI:10.1056/nejmoa2405008
摘要
Zenocutuzumab showed efficacy in patients with advanced NRG1 fusion-positive cancer, notably NSCLC and pancreatic cancer, with mainly low-grade adverse events. (Funded by Merus; eNRGy ClinicalTrials.gov number, NCT02912949.).
科研通智能强力驱动
Strongly Powered by AbleSci AI